Exploring Synergistic Treatment Strategies for Migraine With Monoclonal Antibodies and Gepants: Stewart J Tepper, MD – Neurology Live

Read article - Features a video clip of Stewart J. Tepper, a professor of neurology, talking about migraine prevention. “I look forward to a phase 3 trial with this monoclonal antibody and hope that we have a new target in migraine prevention,” Tepper said.